智能水凝胶辅助肝癌治疗。

IF 11 1区 综合性期刊 Q1 Multidisciplinary Research Pub Date : 2024-10-14 eCollection Date: 2024-01-01 DOI:10.34133/research.0477
Zixiang Tang, Lin Deng, Jing Zhang, Tao Jiang, Honglin Xiang, Yanyang Chen, Huzhe Liu, Zhengwei Cai, Wenguo Cui, Yongfu Xiong
{"title":"智能水凝胶辅助肝癌治疗。","authors":"Zixiang Tang, Lin Deng, Jing Zhang, Tao Jiang, Honglin Xiang, Yanyang Chen, Huzhe Liu, Zhengwei Cai, Wenguo Cui, Yongfu Xiong","doi":"10.34133/research.0477","DOIUrl":null,"url":null,"abstract":"<p><p>Given the high malignancy of liver cancer and the liver's unique role in immune and metabolic regulation, current treatments have limited efficacy, resulting in a poor prognosis. Hydrogels, soft 3-dimensional network materials comprising numerous hydrophilic monomers, have considerable potential as intelligent drug delivery systems for liver cancer treatment. The advantages of hydrogels include their versatile delivery modalities, precision targeting, intelligent stimulus response, controlled drug release, high drug loading capacity, excellent slow-release capabilities, and substantial potential as carriers of bioactive molecules. This review presents an in-depth examination of hydrogel-assisted advanced therapies for hepatocellular carcinoma, encompassing small-molecule drug therapy, immunotherapy, gene therapy, and the utilization of other biologics. Furthermore, it examines the integration of hydrogels with conventional liver cancer therapies, including radiation, interventional therapy, and ultrasound. This review provides a comprehensive overview of the numerous advantages of hydrogels and their potential to enhance therapeutic efficacy, targeting, and drug delivery safety. In conclusion, this review addresses the clinical implementation of hydrogels in liver cancer therapy and future challenges and design principles for hydrogel-based systems, and proposes novel research directions and strategies.</p>","PeriodicalId":21120,"journal":{"name":"Research","volume":"7 ","pages":"0477"},"PeriodicalIF":11.0000,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11651419/pdf/","citationCount":"0","resultStr":"{\"title\":\"Intelligent Hydrogel-Assisted Hepatocellular Carcinoma Therapy.\",\"authors\":\"Zixiang Tang, Lin Deng, Jing Zhang, Tao Jiang, Honglin Xiang, Yanyang Chen, Huzhe Liu, Zhengwei Cai, Wenguo Cui, Yongfu Xiong\",\"doi\":\"10.34133/research.0477\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Given the high malignancy of liver cancer and the liver's unique role in immune and metabolic regulation, current treatments have limited efficacy, resulting in a poor prognosis. Hydrogels, soft 3-dimensional network materials comprising numerous hydrophilic monomers, have considerable potential as intelligent drug delivery systems for liver cancer treatment. The advantages of hydrogels include their versatile delivery modalities, precision targeting, intelligent stimulus response, controlled drug release, high drug loading capacity, excellent slow-release capabilities, and substantial potential as carriers of bioactive molecules. This review presents an in-depth examination of hydrogel-assisted advanced therapies for hepatocellular carcinoma, encompassing small-molecule drug therapy, immunotherapy, gene therapy, and the utilization of other biologics. Furthermore, it examines the integration of hydrogels with conventional liver cancer therapies, including radiation, interventional therapy, and ultrasound. This review provides a comprehensive overview of the numerous advantages of hydrogels and their potential to enhance therapeutic efficacy, targeting, and drug delivery safety. In conclusion, this review addresses the clinical implementation of hydrogels in liver cancer therapy and future challenges and design principles for hydrogel-based systems, and proposes novel research directions and strategies.</p>\",\"PeriodicalId\":21120,\"journal\":{\"name\":\"Research\",\"volume\":\"7 \",\"pages\":\"0477\"},\"PeriodicalIF\":11.0000,\"publicationDate\":\"2024-10-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11651419/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Research\",\"FirstCategoryId\":\"103\",\"ListUrlMain\":\"https://doi.org/10.34133/research.0477\",\"RegionNum\":1,\"RegionCategory\":\"综合性期刊\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"Multidisciplinary\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research","FirstCategoryId":"103","ListUrlMain":"https://doi.org/10.34133/research.0477","RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Multidisciplinary","Score":null,"Total":0}
引用次数: 0

摘要

鉴于肝癌的高恶性程度以及肝脏在免疫和代谢调节中的独特作用,目前的治疗效果有限,预后较差。水凝胶是由许多亲水性单体组成的软三维网络材料,作为肝癌治疗的智能药物输送系统具有相当大的潜力。水凝胶具有多种给药方式、精确靶向、智能刺激反应、药物释放控制、高载药能力、优异的缓释能力以及作为生物活性分子载体的巨大潜力。本文综述了水凝胶辅助肝细胞癌的先进治疗方法,包括小分子药物治疗、免疫治疗、基因治疗和其他生物制剂的应用。此外,它还研究了水凝胶与传统肝癌治疗的结合,包括放射、介入治疗和超声。本文综述了水凝胶的众多优势及其在提高治疗疗效、靶向性和给药安全性方面的潜力。综上所述,本文综述了水凝胶在肝癌治疗中的临床应用,以及未来水凝胶系统的挑战和设计原则,并提出了新的研究方向和策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Intelligent Hydrogel-Assisted Hepatocellular Carcinoma Therapy.

Given the high malignancy of liver cancer and the liver's unique role in immune and metabolic regulation, current treatments have limited efficacy, resulting in a poor prognosis. Hydrogels, soft 3-dimensional network materials comprising numerous hydrophilic monomers, have considerable potential as intelligent drug delivery systems for liver cancer treatment. The advantages of hydrogels include their versatile delivery modalities, precision targeting, intelligent stimulus response, controlled drug release, high drug loading capacity, excellent slow-release capabilities, and substantial potential as carriers of bioactive molecules. This review presents an in-depth examination of hydrogel-assisted advanced therapies for hepatocellular carcinoma, encompassing small-molecule drug therapy, immunotherapy, gene therapy, and the utilization of other biologics. Furthermore, it examines the integration of hydrogels with conventional liver cancer therapies, including radiation, interventional therapy, and ultrasound. This review provides a comprehensive overview of the numerous advantages of hydrogels and their potential to enhance therapeutic efficacy, targeting, and drug delivery safety. In conclusion, this review addresses the clinical implementation of hydrogels in liver cancer therapy and future challenges and design principles for hydrogel-based systems, and proposes novel research directions and strategies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Research
Research Multidisciplinary-Multidisciplinary
CiteScore
13.40
自引率
3.60%
发文量
0
审稿时长
14 weeks
期刊介绍: Research serves as a global platform for academic exchange, collaboration, and technological advancements. This journal welcomes high-quality research contributions from any domain, with open arms to authors from around the globe. Comprising fundamental research in the life and physical sciences, Research also highlights significant findings and issues in engineering and applied science. The journal proudly features original research articles, reviews, perspectives, and editorials, fostering a diverse and dynamic scholarly environment.
期刊最新文献
Erratum to "Sleep Promotion by 3-Hydroxy-4-iminobutyric Acid in Walnut Diaphragma Juglandis Fructus". Mesenchymal Stem Cells Carrying Viral Fusogenic Protein p14 to Treat Solid Tumors by Inducing Cell-Cell Fusion and Immune Activation. Fluorescent Particles Based on Aggregation-Induced Emission for Optical Diagnostics of the Central Nervous System. Biosynthesis of Lysosomally Escaped Apoptotic Bodies Inhibits Inflammasome Synthesis in Macrophages. Crosstalk between Gut Microbiota and Cancer Immunotherapy: Present Investigations and Future Perspective.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1